A Study of Tislelizumab in Combination With Investigational Agents in Participants With Head and Neck Squamous Cell Carcinoma
Clinical trial NCT05909904 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05909904
- Sponsor
- BeiGene
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-02
- Primary completion
- 2025-06-17
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.